methylfurmethide
SMILES | Cc1ccc(o1)C[N+](C)(C)C |
InChIKey | KOWVJDFMEZKDDT-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 1 |
Hydrogen bond donors | 0 |
Rotatable bonds | 2 |
Molecular weight (Da) | 154.1 |
Drug properties
Molecular type | Small molecule |
Endogenous/Surrogate | Surrogate |
Approved drug | No |
Database connections
Ligand site mutations | M2 |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
S1P1 | S1PR1 | Human | Lysophospholipid (S1P) | A | pEC50 | 8.4 | 8.6 | 8.8 | Guide to Pharmacology |
S1P3 | S1PR3 | Human | Lysophospholipid (S1P) | A | pEC50 | 7.8 | 8.6 | 9.4 | Guide to Pharmacology |
S1P4 | S1PR4 | Human | Lysophospholipid (S1P) | A | pEC50 | 8.3 | 8.35 | 8.4 | Guide to Pharmacology |
S1P5 | S1PR5 | Human | Lysophospholipid (S1P) | A | pEC50 | 8.0 | 8.85 | 9.7 | Guide to Pharmacology |
S1P1 | S1PR1 | Human | Lysophospholipid (S1P) | A | pEC50 | 9.1 | 9.1 | 9.1 | ChEMBL |
S1P3 | S1PR3 | Human | Lysophospholipid (S1P) | A | pEC50 | 8.2 | 8.2 | 8.2 | ChEMBL |
S1P4 | S1PR4 | Human | Lysophospholipid (S1P) | A | pEC50 | 8.9 | 8.9 | 8.9 | ChEMBL |
S1P5 | S1PR5 | Human | Lysophospholipid (S1P) | A | pEC50 | 8.7 | 8.7 | 8.7 | ChEMBL |